SK280578B6 - Derivát izatinoxímu, spôsob jeho prípravy, farmace - Google Patents
Derivát izatinoxímu, spôsob jeho prípravy, farmace Download PDFInfo
- Publication number
- SK280578B6 SK280578B6 SK238-94A SK23894A SK280578B6 SK 280578 B6 SK280578 B6 SK 280578B6 SK 23894 A SK23894 A SK 23894A SK 280578 B6 SK280578 B6 SK 280578B6
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- isatinoxime
- branched
- formula
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/45—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75116591A | 1991-08-28 | 1991-08-28 | |
US83185192A | 1992-02-05 | 1992-02-05 | |
PCT/EP1992/001999 WO1993005043A1 (en) | 1991-08-28 | 1992-08-27 | Novel isatinoxime derivatives, their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
SK23894A3 SK23894A3 (en) | 1994-12-07 |
SK280578B6 true SK280578B6 (sk) | 2000-04-10 |
Family
ID=27115380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK238-94A SK280578B6 (sk) | 1991-08-28 | 1992-08-27 | Derivát izatinoxímu, spôsob jeho prípravy, farmace |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0529636B1 (ru) |
JP (1) | JP3170584B2 (ru) |
KR (1) | KR100277481B1 (ru) |
AT (1) | ATE181552T1 (ru) |
AU (1) | AU655672B2 (ru) |
CA (1) | CA2076948C (ru) |
CZ (1) | CZ282759B6 (ru) |
DE (1) | DE69229461T2 (ru) |
DK (1) | DK0529636T3 (ru) |
FI (1) | FI107156B (ru) |
GE (1) | GEP20002329B (ru) |
HU (2) | HUT70753A (ru) |
MX (1) | MX9204914A (ru) |
NO (1) | NO301117B1 (ru) |
PL (1) | PL170920B1 (ru) |
RU (1) | RU2114827C1 (ru) |
SK (1) | SK280578B6 (ru) |
WO (1) | WO1993005043A1 (ru) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0664807B1 (en) | 1992-10-13 | 1997-09-10 | Warner-Lambert Company | Quinoxalinedione derivatives as eaa antagonists |
US5843945A (en) * | 1993-05-13 | 1998-12-01 | Neurosearch A/S | AMPA antagonists and a method of treatment |
ATE161259T1 (de) * | 1993-05-13 | 1998-01-15 | Neurosearch As | Ampa antagonisten und behandlungsmethode |
DK81593D0 (da) * | 1993-07-07 | 1993-07-07 | Neurosearch As | Nye isatinoximderivater, deres fremstilling og anvendelse |
DE69514533T2 (de) * | 1994-09-14 | 2000-07-06 | Neurosearch A/S, Ballerup | Kondensierte indole und chinoxalinderivate, ihre herstellung und verwendung als glutamatantagonisten |
US5917053A (en) * | 1994-09-14 | 1999-06-29 | Neurosearch A/S | Indole-2,3-dione-3-oxime derivatives, their preparation and use |
UA54403C2 (ru) * | 1996-10-01 | 2003-03-17 | Н'Юросерч А/С | Производные индол-2,3-дион-3-оксима, фармацевтическая композиция, способ лечения расстройства или заболевания млекопитающих, в том числе человека и способ получения производных индол-2,3-дион-3-оксима |
FR2768624B1 (fr) * | 1997-09-25 | 1999-11-12 | Oreal | Utilisation d'un inhibiteur d'acides amines excitateurs dans une composition cosmetique ou dermatologique pour peaux sensibles et composition obtenue |
ATE420636T1 (de) | 1999-05-19 | 2009-01-15 | Painceptor Pharma Corp | Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen |
CN1298704C (zh) | 2000-01-24 | 2007-02-07 | 神经研究公司 | 具有神经营养活性的靛红衍生物 |
JP4505410B2 (ja) | 2002-10-29 | 2010-07-21 | サングキュンクワン ユニヴァースィティ | モルヒネへの心理的依存又は耐性を防止及び処置するのに有効成分としてベルベリンを含有する医薬組成物 |
CA2630617C (en) | 2005-11-23 | 2014-03-25 | Painceptor Pharma Corporation | Compositions and methods for modulating gated ion channels |
CN104995171B (zh) * | 2012-12-19 | 2018-02-06 | 拜耳作物科学股份公司 | 作为杀真菌剂的二氟甲基‑烟碱‑茚满基甲酰胺 |
US9815768B2 (en) * | 2014-02-28 | 2017-11-14 | Sumitomo Chemical Company, Limited | Method for producing 2-(halogenomethyl)-3-methylnitrobenzene |
WO2017160933A1 (en) | 2016-03-17 | 2017-09-21 | Fmc Corporation | Process for converting s-enantiomer to its racemic form |
CN112266368B (zh) * | 2017-11-15 | 2024-03-19 | 中山光禾医疗科技有限公司 | 光交联水凝胶材料的制备、原料、产品及应用 |
CN108912127B (zh) * | 2018-08-27 | 2019-12-10 | 青岛农业大学 | 一种基于靛红骨架的苯并[b,e]氮杂卓化合物及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE69677B1 (en) * | 1989-12-11 | 1996-10-02 | Neurosearch As | Isatine derivatives their preparation and use |
-
1992
- 1992-08-26 CA CA002076948A patent/CA2076948C/en not_active Expired - Fee Related
- 1992-08-26 MX MX9204914A patent/MX9204914A/es not_active IP Right Cessation
- 1992-08-27 AU AU24820/92A patent/AU655672B2/en not_active Ceased
- 1992-08-27 AT AT92114654T patent/ATE181552T1/de not_active IP Right Cessation
- 1992-08-27 DK DK92114654T patent/DK0529636T3/da active
- 1992-08-27 WO PCT/EP1992/001999 patent/WO1993005043A1/en active IP Right Grant
- 1992-08-27 KR KR1019940700676A patent/KR100277481B1/ko not_active IP Right Cessation
- 1992-08-27 RU RU94019425/04A patent/RU2114827C1/ru not_active IP Right Cessation
- 1992-08-27 JP JP50493393A patent/JP3170584B2/ja not_active Expired - Fee Related
- 1992-08-27 GE GEAP19922683A patent/GEP20002329B/en unknown
- 1992-08-27 EP EP92114654A patent/EP0529636B1/en not_active Expired - Lifetime
- 1992-08-27 SK SK238-94A patent/SK280578B6/sk unknown
- 1992-08-27 HU HU9400595A patent/HUT70753A/hu unknown
- 1992-08-27 DE DE69229461T patent/DE69229461T2/de not_active Expired - Lifetime
- 1992-08-27 CZ CZ94395A patent/CZ282759B6/cs not_active IP Right Cessation
- 1992-08-27 PL PL92302584A patent/PL170920B1/pl unknown
-
1994
- 1994-02-25 NO NO940676A patent/NO301117B1/no unknown
- 1994-02-25 FI FI940889A patent/FI107156B/fi active
-
1995
- 1995-06-21 HU HU95P/P00323P patent/HU211632A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AU655672B2 (en) | 1995-01-05 |
GEP20002329B (en) | 2000-12-25 |
CA2076948C (en) | 2002-04-16 |
HU9400595D0 (en) | 1994-05-30 |
DK0529636T3 (da) | 1999-12-13 |
HUT70753A (en) | 1995-10-30 |
EP0529636B1 (en) | 1999-06-23 |
SK23894A3 (en) | 1994-12-07 |
RU2114827C1 (ru) | 1998-07-10 |
FI940889A0 (fi) | 1994-02-25 |
ATE181552T1 (de) | 1999-07-15 |
FI107156B (fi) | 2001-06-15 |
KR100277481B1 (ko) | 2001-02-01 |
JP3170584B2 (ja) | 2001-05-28 |
NO940676D0 (no) | 1994-02-25 |
EP0529636A1 (en) | 1993-03-03 |
CZ39594A3 (en) | 1994-11-16 |
DE69229461T2 (de) | 1999-10-21 |
WO1993005043A1 (en) | 1993-03-18 |
PL170920B1 (pl) | 1997-02-28 |
DE69229461D1 (de) | 1999-07-29 |
CA2076948A1 (en) | 1993-03-01 |
NO940676L (ru) | 1994-04-27 |
FI940889A (fi) | 1994-02-25 |
AU2482092A (en) | 1993-04-05 |
CZ282759B6 (cs) | 1997-09-17 |
JPH06510056A (ja) | 1994-11-10 |
NO301117B1 (no) | 1997-09-15 |
HU211632A9 (en) | 1995-12-28 |
MX9204914A (es) | 1993-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK280578B6 (sk) | Derivát izatinoxímu, spôsob jeho prípravy, farmace | |
AU599340B2 (en) | Condensed imidazopyridine derivatives | |
KR100192641B1 (ko) | 하이드라존 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
EA002123B1 (ru) | Соединения, усиливающие активность ретиноидов | |
Walser et al. | Pentacyclic triazolodiazepines as PAF‐antagonists | |
Hussenether et al. | Clozapine derived 2, 3-dihydro-1H-1, 4-and 1, 5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing | |
JP3010558B2 (ja) | 新規の1,7‐融合1h‐インドール‐2‐カルボン酸‐n‐(1,4‐ベンゾジアゼピン‐3‐イル)‐アミド、その製法及びこれを含有するコレシストキニン拮抗作用薬剤 | |
US7329653B2 (en) | Cyclohexylphenyl vasopressin agonists | |
NO172437B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimidindionforbindelser | |
Huff et al. | Bioactive conformation of 1-arylpiperazines at central serotonin receptors | |
JP2001114781A (ja) | 新規な多環式アザインドール化合物、それらの調製方法およびそれらを含有する薬学的組成物 | |
DE60218646T2 (de) | N-biphenylcarbonyl- und n-phenylpyridylcarbonyl substituierte bi- und tricyclische azepine und diazepine als vasopressin-agonisten | |
AU780027B2 (en) | New indenoindolone compounds, a process for their preparation and pharmaceutical compositions containing them | |
EP0233049A1 (en) | 2,3,4,8,9,9a-Hexahydro-4-aryl-1H-indeno[1,7-cd]azepines | |
DE3587556T2 (de) | 2-Substituierte Aminomethyl-1,4-benzodiazepine, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
HU202239B (en) | Process for producing benzodiazepine derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
US5436250A (en) | Isatineoxime derivatives, their preparation and use | |
US5242918A (en) | Isatinoxime derivatives, their preparation and use | |
CS226743B2 (en) | Method of preparing new 1,4,9,10-tetrahydropyrazolo (4,3-e)pyrido (3,2-b) l,4)diazepin-10-ones | |
UA79801C2 (en) | Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications | |
WO2000027851A1 (en) | Novel type condensed pyridazinone compounds | |
KR19980020007A (ko) | 1,4-벤조디아제핀-2,5-디온 유도체 및 약학적으로 허용되는 그의 염 |